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Abstract: In order to better understand and predict the release of proteins
from bioerodible micro- or nanospheres, it is important to know the influences
of different initial factors on the release mechanisms. Often though it is diffi-
cult to assess what exactly is at the origin of a certain dissolution profile. We
propose here a new class of fine-grained multi-agent models built to incorpo-
rate increasing complexity, permitting the exploration of the role of different
parameters, especially that of the internal morphology of the spheres, in the
exhibited release profile. This approach, based on Monte-Carlo (MC) and
Cellular Automata (CA) techniques, has permitted the testing of various as-
sumptions and hypotheses about several experimental systems of nanospheres
encapsulating proteins. Results have confirmed that this modelling approach
has increased the resolution over the complexity involved, opening promis-
ing perspectives for future developments, especially complementing in vitro
experimentation.
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1 Introduction
In this paper, a range of multi-agent models for simulating dissolution of
macromolecules from bioerodible spheres is introduced. Bioerodible micro-
and nanospheres, encapsulating large molecules such as proteins, have been
at the cutting-edge of development in the area of novel drug delivery systems
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for sustained release, with applications in bioengineering fields including bone
repair, tissue engineering and development [3, 21, 6], as well as in biomedical
areas such as vaccine delivery, various chemotherapies for treatments of can-
cer, AIDS, tuberculosis, diseases of the central nervous system [5, 20, 12, 4]
and others. Interest in using biodegradable materials lies in the fact that the
products of dissolution of the particles are biocompatible and biodegradable,
hence they do not require further manipulation after introduction to the body
[21]. This makes bioerodible particulates suitable for use under minimum in-
vasive surgery [16], providing greater patient compliance.
In particular, the present paper focuses on drug delivery systems using
poly(lactide-co-glycolide) (PLGA) as a bioerodible material to encapsulate
proteins and other large molecules. This non-toxic, biodegradable material
is widely used in the controlled-release community, because its physical and
chemical properties permit the manufacture of a large spectrum of micro-
and nanoparticles, generating various release profiles for the encapsulated
drug. Recent work [18, 15] has also indicated that these drug carriers exhibit
extremely complex dissolution behaviour. Experimentation in vitro is both
costly and time-consuming: the release period for a PLGA particle can range
from 3 weeks to 1 year [21], hence an increased interest for complementary
modelling and simulations.
In silico modelling of dissolution from PLGA spheres has proved to be
a very laborious task in the reduction and replacement of such in vitro ex-
perimentation. PLGA is a bulk-eroding material so erosion takes place slower
than the hydration of the particles. As a result, the erosion occurs through
the entire volume of the spheres, creating a network of pores and channels
through which the encapsulated molecules escape the delivery system, so the
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modelled system is non-homogeneous. Figure 1 illustrates the principle of bulk
erosion compared to the more common process of surface erosion.
Fig. 1. Bulk erosion versus surface erosion.
In the dissolution of PLGA spheres, we can distinguish two simultaneous
processes which need to be modelled: i) the erosion of the polymer and ii) the
dissolution of the encapsulated molecule. An approach, recently gaining popu-
larity in modelling polymer erosion, is based on direct MC and CA methods.
In the case of bioerodible polymers, the work of Göpferich [7, 9, 6, 8] and
Zygourakis [25] has shown that polymers, their properties and the process of
their dissolution can be modelled microscopically by means of computational
grids with transient behaviour. The eventual release of an encapsulated drug
is considered to be directly proportional to the erosion of polymer [9, 8]. This
approach, usually based on the assumption that the polymer has a homoge-
neous inner structure, aims for a good representation of the geometrical form
of the devices, as well as of the physical and chemical interactions inside the
matrix, and has led to promising results and potential for further development.
A range of models, based on numerical solutions of differential equations,
focusing more on the second process, (the dissolution of the encapsulated
molecule), simulates the concentrations of diffusing species within and external
to the spheres [2, 10, 19, 23]. Methods based on differential equations require,
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for example, continuous spatial distributions, hence they consider porous 3D
morphologies indirectly, in introducing porosity parameters that affect the
diffusion coefficients through time and space [23, 10, 19]. In [10, 19], previous
work involving microscopic models based on MC was used in order to calculate
the porosity parameters needed to solve the differential equations.
To date 1) there are no reports using fine-grained models to analyse the
effects of the internal morphologies of PLGA spheres on the dissolution pro-
files and 2) there are no microscopic models directly taking into consideration
the dissolution of proteins from PLGA devices. However, recently published,
parallel work has shown the interest of the researchers in developing more
sophisticated microscopic models for polymeric applications in drug delivery.
For example, the proteins are viewed as distinct entities in a very interest-
ing microscopic model for the release of proteins from cross-linked dextran
microspheres [22].
In the present study, PLGA drug carriers were represented as complex
3D systems, departing from the idea that, in addition to the factors already
considered in the cited literature, in the case of protein dissolution, both
the pre-existent and dynamically formed pores influence in a direct way the
resulting protein release profile. This work examines, in a very fine-grained
manner, the 3D internal morphologies of nanospheres, using MC agent-based
models to explicitly simulate not only the erosion of the PLGA, but also the
dissolution of the proteins themselves. The models were tested on experimental
data from Sandor et al. [18], demonstrating very good performance. This
work completes and also complements previous work done on probabilistic
microscopic modelling of drug dissolution, demonstrating new possibilities of
the multi-agent computational modelling techniques in a concrete example.
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2 Theory
In the case of PLGA spheres, the range of factors responsible for variations
in the dissolution profiles generated and/or inter-relationships of interacting
factors is wide, and those with a crucial impact on the final dissolution profile
are not straightforward to separate, [18]. However several general points may
be made:
• In general, the drug release rate from PLGA spheres is controlled by the
degradation rate of the PLGA co-polymer [11, 21, 2]. Selecting adequate
formulation conditions, such as polymer type and preparation method, can
generally regulate degradation rate. For example, the use of copolymers of
PLGA of different molecular weight, hydrophilicity and copolymer com-
position (the ratio of lactide to glycolide) has been found to change initial
hydration and erosion rate for the matrix [11, 21].
• The structure of the porous environment in the spheres also governs the
protein release rate, (see Figure 2). The sphere processing parameters and
copolymer composition is known to influence the extent of crystallinity
and therefore the ratio of smaller to larger pores in the sphere [2]. The
method of sphere preparation and molecule encapsulation plays a basic
role in regulating the porosity factor. The type of encapsulated protein
also has considerable influence on the inner morphology [18].
• In addition, drug diffusion in the pores influences the overall drug release
profile and is conditioned by a group of factors such as molecular prop-
erties (hydrophilicity, size) and drug distribution (size distribution of the
encapsulated powder particles and distribution of this powder inside the
sphere, Figure 2).
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Fig. 2. a) Sphere morphology obtained by the solid-in-oil-in-water solvent evapo-
ration technique [21]. b) Sphere morphology obtained by water- in-oil-in-water [21]
solvent evaporation technique. Adapted from Ungaro et al. [21].
It is more difficult to modify the release characteristics of the spheres, once
a polymer type and a preparation technique have been selected [21]. In this
case, control over the release rate may be maintained either by modifying the
internal morphology of the system (the porosity pattern) or adding a third
component that alters drug effective diffusivity in the polymeric matrix [21].
A wide range of dissolution profiles can be generated by using PLGA
spheres, but the most typical profile, with its three dissolution phases, (de-
scribed in [2]), is given in Figure 3.
Fig. 3. Phases of protein release from PLGA microspheres, differing by shape of
the curve and by dissolution mechanism: a) initial burst related to desorption or
dissolution. b) erosion and diffusion. c) mostly erosion and diffusion.
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The combination of parameters mentioned and the initial morphology of
the sphere determine existence and duration of phases.
3 Modelling
The dimensions of the experimental entities involved range from several
nanometers (proteins) to several microns (spheres). A comparatively sim-
ple protein example like the lysozyme (13.4 kDa), has a diameter of 3.2 nm
[13]. Diffusion measurements in PLGA micro- and nanospheres encapsulat-
ing lysozymes involve pore sizes < 20 nm [18], so it is reasonable to describe
diffusion in terms of individual random walks of molecules, rather than by
transport of matter through surfaces. Experimental studies [18], have revealed
that, in general, the initial configuration of pores corresponds mostly to sizes
of 5 - 80 nm, (proportional to the size of the encapsulated proteins). Equally,
other experimental studies have reported cases of spheres with initial occlu-
sions much larger than the Stokes-Einstein diameter of the microencapsulated
molecule [2, 3]. Nevertheless, as long as the proteins undergo very restricted
diffusion through pores of i) the same order of magnitude as the proteins
themselves or ii) slightly larger, but where other secondary phenomena, not
specifically modelled here, form obstacles 4, it is appropriate to treat diffusion
by individual random walks of a given number of agents [14, 17]. In such cases,
multi-agent systems seem reasonable approximations for a "protein - PLGA
- pore" system.
4 Sometimes the drug has to move through some narrow passageways which are
produced by the vibrations of the polymer chain and control the actual size for
the passage of macromolecules, [23].
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3.1 Main Characteristics of the Model
The assumptions which apply to all models developed are based on available
experimental data [18]. The polymeric particles, modelled in 3D space, are
considered to be completely spherical. The spheres are discretised throughout
the volume into small sites. Figure 4 represents a schematic diagram of a
section through a sphere during the simulation. The sites are seeded, according
to predefined initial patterns, with elements such as PLGA polymer or protein
molecules. If necessary, an initial porosity value in the PLGA bulk material can
be considered and, over time, more pores are formed. Different strategies for
describing PLGA erosion and pore formation can be considered. The approach
taken here to model the polymer erosion was based on Göpferich’s theory for
polymer erosion [9]. When a site, filled with polymer, reaches a certain stage
of erosion (the value of its lifetime reaches zero [9]), its status changes to
that of a pore. A protein molecule can leave its initial location only in the
case where one of the neighbouring sites is a pore, (i.e. the molecules can
only move through pores). Once in a porous channel, a molecule cannot leave
it, except by escaping the sphere. When a molecule escapes the sphere, it is
counted as dissolved. The internal configuration of the spheres in the model
can be varied, depending on the internal morphology of the experimental
spheres. The algorithm used to perform the simulation can be resumed in the
following:
1. Generate the nanosphere and populate it with the agents.
2. Update the state of the PLGA sites.
3. Update the state of the molecules: they can move or not to a neighboring
pore.
4. Update the time and return to point 2.
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Fig. 4. Simplified scheme representing the main characteristics of the multi-agent
model. Cross section through a 3D sphere.
3.2 Modelling the internal configuration of the spheres
The majority of modelling approaches available such as [23, 9] were designed
for homogeneous distributions of the pores and of proteins in the spheres.
Different aspects, suggesting that, in some cases, the internal configuration of
the spheres might be subject to heterogeneity, are presented here.
The study conducted by Sandor et al. [18] on the effect of microencapsu-
lated molecules on the internal structure of and nanospheres, revealed that
spheres enclosing smaller proteins appear to have an open branched network
throughout. However, those enclosing larger proteins have pores in the outer
layers and appear open near the surface, while having a more dense structure
in the inner layers of the sphere, Figure 5.
Fig. 5. a) Control PLGA sphere, no encapsulated molecules b) PLGA sphere
encapsulating carbonic anhydrase, adapted from Sandor et al. [18].
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Batycky et al. [2] discussed another phenomenon of relevance to micro-
spheres. If it is assumed that adsorption of macromolecules to the surface of
the microsphere (or to the large occlusions inside the spheres), an uneven dis-
tribution of the macromolecule throughout the sphere volume may occur. A
recent 3D reconstruction from transmission electron microscopy (TEM) im-
ages of the transient distribution of albumin in PLGA spheres during erosion
[24] shows an inhomogeneous distribution of the protein. If this uneven dis-
tribution is realistic, the values of parameters, obtained by adjusting models
premised on a homogeneous distribution to experimental data (like in [23]),
will be biased.
Fig. 6. Developmental scheme of the models and their variants.
Further, one should consider as well the possibility that PLGA might de-
grade quicker in the outer layers of the spheres than in the core. From gradient
considerations, the degradation products have higher diffusivity in the mantle
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of the sphere than in its core, thus the relative pore generation rate might
increase more rapidly in the outer compared to the inner layers.
In this multi-agent investigation, these aspects were considered in an ex-
ploratory manner of increasing complexity. For example, the effects of a de-
creasing porosity from the surface to the core of the sphere, or of the protein
adsorbed at the surface of the spheres, were considered by dividing a 3D
sphere into strata and populating these with obstacles, pores and molecules
according to different concentrations. Morphologies like those represented in
Figure 2, (b), were directly taken into consideration by initialising a specific
inner morphology containing both large occlusions filled with proteins and
networks of smaller pores. Figure 6 shows the exploratory scheme of the vari-
ants for different inner morphologies of spheres spanning out of the initial
model, (Figure 4).
For example, three different variants on the initial model A are presented,
Figure 6. Version A.1 considers only stratified pores, with the porosities de-
creasing from the surface towards the centre. Version A.2 considers stratified
concentrations of protein with similar gradient. However, it is reasonable to
assume that layers with large initial porosities are correlated with correspond-
ingly larger concentrations too, as described in [2, 21]. This is incorporated
in version A.1-2. Other developments are also represented on the Figure 6
(models B and C and their variants).
4 Results and discussion
In the simulation, the number of particles per site was sampled from a uniform
distribution between a lower and an upper value: U(a1, a2), a1 < a2. In this
fine-grained simulation, the degrees of freedom, provided for the molecules by
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the von Neumann neighbourhood (Figure 7, (a)), were sufficient to model the
case. For coarser-grained models, e.g. cases where the molecules considered are
much smaller then the site, a Moore’s neighbourhood (Figure 7, (b)) can be
considered, as offering more degrees of freedom. A broad sensitivity analysis
has been carried out on the model, studying the effects on the dissolution
profiles of parameters such as the erosion rate of the polymer, the distribution
of proteins per site, the drug loading, the MC step time-interval (found to be a
measure of the effective diffusivity of the protein), the type of neighbourhood
used, the size of the sphere and the internal morphologies of the spheres. This
section presents a discussion on a few of the most interesting aspects.
a. b.
Fig. 7. a) Von Neumann neighbourhood in 2D. b) Moore’s neighbourhood in 2D.
4.1 Initial porosity and initial macromolecular loading
Experimental work has shown that an increase in drug loading results in a
corresponding increase in the release rate [15, 18]. Sandor et al. [18] have
measured the protein loadings, as a percentage of the total weight of the
nanospheres. Here it is considered in terms of the concentration of sites con-
taining proteins. From the simulations, the loading value, i.e. concentration,
appears to have no significant influence on the dissolution profiles, fact in
accordance with parallel work [22] for release of protein from cross-linked
polymers. Initially, this seems to be inconsistent with experiment, but [18]
suggest that the increase in the release rate at higher loadings actually occurs
due to initial porosity : at low loadings (0.5 -1.6 %), small proteins seem to
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depend on diffusion through pores initially and on degradation at later times.
Spheres with higher loadings are found to have more interconnecting channels.
Sandor et al. [18] consider the channels to be the reason why the higher-loaded
spheres (4.8-6.9 %) do not exhibit the pronounced shift (such as on Figure 8,
filled circles) from diffusion-based (slow dissolution) to polymer release-based
(higher dissolution rate) seen with the lower loaded spheres.
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Fig. 8. Dissolution profile for different values of the initial porosity. Model inputs:
d=100, λ=0.00001,∆t=10 min, c0=0.02, from 1 to 4 particles per site, von Neumann
neighbourhood.
Figure 8 shows the reaction to porosity variation in a sphere (d=100
and λ=0.00001), loaded with particles that are homogeneously distributed
throughout its volume (c0=0.02). As can be observed, even quite small vari-
ations of the initial porosity result in different dissolution profiles beginning
with ∼ day 1 of dissolution.
In relation to the simulation, there is reason to believe that it is not varia-
tion in concentration, but rather the variation of initial porosity, which is the
main basis for modification in dissolution profiles. There is a correlation of the
dissolution profiles with the initial porosity resulting, in all probability, from
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the way the spheres are manufactured. These simulations suggest that more
attention should be dedicated to porosity studies in investigations on micro-
and nanospheres, in order to better describe the connection between the con-
centration of the encapsulated molecule and the resulting initial porosity.
4.2 Influence of the MC time step
The physical meaning of the time interval ∆t, during which the particles of
the model move, is directly related to the mobility of the particles within
the structure. The choice of ∆t is determined by the effective diffusivity of a
molecule in a medium filled with erosion products, such as different monomers.
Smaller molecules have larger effective diffusivities, while larger molecules will
be characterised by very reduced diffusivities [18]. Dimensional analysis has
shown that in the cases of small to medium-sized proteins, ∆t is of the order
of seconds [1].
The spheres used in this simulation had porosity organised in 3 strata, with
value decreasing from the mantle to the core. The simulation indicated more
clearly the mechanisms behind the dissolution profiles. The smaller ∆t is, the
more frequently the particle may update, i.e. move to a neighbouring site with
a specified probability. Figure 9, (t>20 days), shows that, in the case where the
environment permits mobility, (right hand side of the graphs), different values
for ∆t can considerably change the rate of dissolution profile. The spheres
started at zero initial porosity, but a small initial burst of particles released
can still be observed. Further, the porosity was allowed to increase slowly,
(λ=0.00001). At day 16, when the value of the porosity reached the threshold
value of pth=0.2, clusters of pores spanning the whole sphere started forming,
hence the dissolution profiles begin to diverge according to the different values
of ∆t used.
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Fig. 9. Effect of the time step used to perform the updating in the simulation.
The fact that the problem is separable into two time domains - a fast do-
main representing the initial burst phase related to release of proteins from the
pores connected to the outside, and a slow domain corresponding to formation
of new connected pores by erosion - would actually permit an optimisation
to the simulation. Simulating the initial phase with a very small ∆t would
permit to obtain more accurate representations of the burst phase.
4.3 Effect of internal morphology of the spheres
Figure 10 shows a comparison between the basic model A and its variants A.1
and A.1-2. Table 1 details the width of the strata, deliberately chosen in such
a way that in each variant the initial porosity of the generated spheres was
almost the same. Figure 10, (a) shows how the three variants behave with
reduced initial porosity. Figures 10, (b) illustrate the behaviour of the three
variants for a larger porosity. These results suggest that stratification of the
porosity has a smaller role relative to the stratification of the molecule con-
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centration. It also demonstrates that the internal morphology of the spheres
is an important factor in modelling the micro- or nanosphere system.
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Fig. 10. Dissolution through spheres with homogeneous porosity (circles), spheres
with stratified porosity (triangles) and combined stratified pores and stratified con-
centration (reversed triangles). a) p0 = 0.05 b) p0 = 0.2
4.4 Comparison with experimental data
To use the model and its variants for quantitative evaluations or predictions,
initial specification of the microspheres is needed. Table 2 gives a list of pa-
rameters of the model. The values of these parameters have to be determined
for every case to which the model is applied, because they are directly related
to the internal structure and properties of the spheres. For the rest of this
section, the results from the simulations are compared to real data.
4.5 Experimental Case 1: Lysozyme
In this subsection, the models are validated by comparing their performance
to real data. The experimental data set from Sandor et al. [18] relates to a
set of nanospheres encapsulating a very small protein, the lysozyme. Table 3
specifies the information available on this system.
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Fig. 11. a) Sphere with similar internal morphology to that used to model release
of lysozyme. b) Experimental lyzosyme release versus simulated drug release from
biodegradable microspheres. Rhombi represent the experimental points from [18].
Continuous curves show simulated results obtained with different ∆t values.
The spheres have been analysed by electronic microscopy and they appear
compact and non-porous [18]. This means that the pores, if these exist, have
diameters < 20 nm i.e. below the resolution levels of the microscopy technique
[18]. The existence of very small pores of 5 nm in diameter, (just above the
Stokes-Einstein diameter of the lysozyme, 3 nm), has been assumed in the
simulation. Given the diameter of the sphere d and the diameter of the pore
pd it was decided to run the simulations with spheres of 50 sites in diameter,
(i.e. taking 5 nm as the diameter of one site). The λ parameter was chosen to
be 5× 10−6s−1 (corresponding to the erosion of the sphere in about 50 days).
It was not known whether the pores were organised in strata or not, but,
given that for slightly larger nanospheres, (encapsulating larger molecules,
such as carbon anhydrase), porosities are known to be stratified [18], so it
can be assumed here that spheres carrying lysozyme have stratified porosities
as well. Models A, A1, A2 and A.1-2 have been tested for this system. Only
model A.1-2 (model variant with stratified pores and stratified concentrations)
has well replicated the experimental dissolution curves. Three different values
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of 4t have been chosen. The best results are obtained with the smallest time
step: 4t=6 s, Figure 11, (b). Indeed, dimensional analysis has demonstrated
that a4t of the order of seconds is a correct measure of the effective diffusivity
of a protein in an eroding polymer medium [1]. In Figure 11, (b), the points
indicating a slow release experimental curve correspond to an initial loading
of 1.6% and the curve of very fast release has been obtained by Sandor et al.
[18] with an initial loading of 6.9% of total weight.
4.6 Experimental Case 2: Carbonic Anhydrase
This subsection summarises results obtained with the model calibrated to
simulate release of carbonic anhydrase from microspheres of size '1 µm, de-
scribed, like previous spheres, in Sandor et al. [18]. This type of sphere has a
very different initial internal morphology to the case examined previously. It
is characterised by quite large internal pores and channels, which appear to be
much larger then the protein diameter (carbon anhydrase). A model variant
where initial pores were permitted to be larger in size than one site (C and
variants) has been thus chosen. Figure 12, (a) shows a typical cross-section
through a sphere generated with model C. In addition, most molecules are ini-
tially concentrated in these pores [2, 21]. In this model variant, most proteins
are situated in the occlusions, but some are trapped in the bulk PLGA as
well. The occlusions are slightly stratified, such that they are more prevalent
at the surface of the spheres, replicating the pattern observed, Figure 5, (b).
Table 4 shows the sphere data and modelling basis.
Figure 12, (b) illustrates the model’s C.1.1 performance. The simulated
slow release curve has been obtained with an initial porosity of 0.14 and the
rapid release curve with initial porosity p0=0.33. The experimental data were
based on a population of spheres with average diameter of 1 µm. It should
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a) b)
Fig. 12. a) Internal morphology of the spheres for simulating dissolution of carbonic
anhydrase from PLGA spheres of ' 1µm diameter. b) Experimental carbonic anhy-
drase versus simulated drug release from biodegradable microspheres. Red rhombi
represent the experimental points from [18]. Continuous curves show simulated re-
sults obtained with different ∆t values.
be noted that, in our experience, models variants which do not take into
consideration the occlusions and the proteins trapped inside these, do not
produce release profiles in agreement with known experimental dissolution
profiles.
While microsphere internal structure is determined by the given exper-
imental context, what the multi-agent approach actually does is provide a
framework to allow us to determine those parameters based on emergent be-
haviour observed (or postulated) for the system, and not to rely on a complete
knowledge of the ab initio conditions. The value of modelling work is that the
framework, once developed, complements situations, where accurate experi-
mentation is difficult, since it enables postulation of plausible system values
and analysis of outcomes over a range. For example, in the case of nanospheres
charged with lysozyme, the electronic microscopy was not sufficient to deter-
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mine the inner structure of the spheres. Instead, we have made a range of
assumptions about the internal morphology of the spheres, and several ver-
sions of the models where used to confirm or reject these assumptions, as
described above.
5 Conclusions
The results of this multi-agent exploratory approach to modelling protein
release from bioerodible PLGA spheres have demonstrated that Direct MC
models can give very good quantitative agreement with experiment if enough
consideration is given to the details (i.e. physical properties of spheres, pa-
rameter values,model variant etc). From the simulation technique point of
view the major improvement in this work is the very fine-grained description
of the systems, the close examination of the internal morphologies and the
use of agents in the model building (for modelling the proteins). The models
developed can be used in the optimisation process, by indicating what type of
inner morphologies optimise the desired dissolution profile, and, in addition,
for the inverse problem: assessment of the inner morphology of spheres based
on the dissolution profiles, when microscopy data is not available.
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Table 1. Details on the stratification of the spheres used to obtain the results from
Figure 10. r represents the radius of a sphere in number of sites, p0 and c0 are,
respectively, the input porosity and concentration.
Stratum1 Stratum2 Stratum3
Depth of stratum (sites) 0.15r 0.25r 0.6r
Porosity 1.5p0 0.7p0 0.3p0
Concentration 1.5c0 0.7c0 0.3c0
Table 2. Quantities needed for the simulation of protein dissolution from micro-
spheres
Description Variable
Size of the sphere d
Effective diffusivity/mobility of the macromolecules through the pores Deff
Diffusivity of the macromolecules in the solvent D0
Diameter of the macromolecules a
Sphere loading c
Concentration of the macromolecule at different depths of the sphere c01, c02, c03
Size of the pore one wish to consider pd
Initial porosity p0
Pattern of repartition of pores in the volume of the sphere p01, p02, p03
Rate of pore formation λ
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Table 3. Properties of nanospheres loaded with lysozyme; corresponding modelling
choices taken after evaluation of this data
Variable Value Model
d 200-250 nm 50 sites
Deff N/A ∆t =10min, 1min and 6 sec
D0 N/A not needed here
a '3 nm -
c0 1.6% and 6.9% of total weight c0low =0.016 and c0high =0.069
c01 /c02 /c03 N/A c0 /0.5c0/0.2c0
pd >20 nm 5 nm/site
p0 N/A p0low =0 and p0high =0.3
p01 /p02 /p03 N/A p0 /0.3p0 /0
λ N/A 5× 10−6
Table 4. Information available on nanospheres loaded with carbonic anhydrase;
corresponding modelling decisions choses based on data evaluation
Variable Value Model
d 1000-1200 nm 100 sites
Deff N/A ∆t =1 min (by dimensional analysis)
D0 N/A not needed here
a ~10 nm -
c0 1.2% and 6% c0low =0.012 and c0high =0.006
c01 /c02 /c03 N/A follows the occlusions
p0 N/A p0low =0.14 and p0high =0.33
p01 /p02 /p03 N/A 2 strata: r1 = 5, r2 = 45 sites and 3p0 /p0
λ N/A 5× 10−6
